ARCHIVES

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014

Cancer Panel Statement On Access To Cancer Care.

October 6, 2000

Peters Replaced As Director Of Karmanos Cancer Center.

December 1, 2000

Ungerleider To Leave NCI For Theradex Corp.

November 24, 2000

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

SEER Expects To Lower Cancer Incidence Rates for Blacks by 3%

September 27, 2002